"alaska"

Highly effective prophylactic vaccines are available for two of the most important cancer-causing infections, hepatitis B virus (HBV) and human papillomavirus (HPV) (see Infection). In 2022, there were an estimated 254 million people globally with chronic HBV infection; HBV infection causes nearly one million deaths annually, mostly from cirrhosis and1